George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshoka India Equity Investment Trust Plc Regulatory News (AIE)

Share Price Information for Ashoka India Equity Investment Trust Plc (AIE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 269.00
Bid: 268.00
Ask: 269.00
Change: 2.00 (0.75%)
Spread: 1.00 (0.373%)
Open: 267.00
High: 271.00
Low: 267.00
Prev. Close: 267.00
AIE Live PriceLast checked at -
Ashoka India Equity is an Investment Trust

To achieve long-term capital appreciation, mainly through investment in securities listed in India and listed securities of companies with a significant presence in India.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results analysis from Kepler Trust Intelligence

20 Mar 2024 10:18

RNS Number : 6059H
Ashoka India Equity Investment Tst
20 March 2024
 

Ashoka India Equity (AIE)

20/03/2024

Results analysis from Kepler Trust Intelligence

Ashoka India Equity (AIE) has released its half-year results for the period ending 31/12/2023. The trust delivered share price and net asset value (NAV) total returns of 16.3% and 15.7% respectively over the period, both in sterling terms. Equivalent returns for the trust's benchmark, the MSCI India IMI Index, were 16.4%.

Despite being flat on the benchmark over the half-year, AIE delivered strong outperformance over 2023 as a whole, with NAV total returns of 24.5%, compared to 18.4% in the benchmark. Since inception in 2018 through to the end of February 2024, the trust delivered annualised NAV total returns of 18.1%, compared to 12.8% for the benchmark.

Chairman Andrew Watkins said: "Both Acorn and White Oak remain focused on delivering outstanding returns from a broadly diversified portfolio of investments from across the market cap spectrum. Your board has great confidence in their abilities to outperform and produce superior returns from one of the world's most dynamic and fastest-growing markets."

Kepler View

Ashoka India Equity (AIE) has been the best-performing India specialist trust since its launch in 2018. The trust has the largest in-country research team in the sector. The managers place a heavy emphasis on corporate governance and valuations, with the latter backed by a proprietary cash-flow centric valuation framework.

India's stock market has had a strong few years, with multiple tailwinds for the country. Firstly, it has been relatively more immune to a strengthening dollar than in the past. There has also been a substantial build-up of foreign reserves, and its economy was not subject to the same sort of inflationary shocks that affected the developed countries in 2022.

Secondly, economic growth has also been strong. India's GDP grew by 7.3% last year, making it the fastest-growing major economy in the world. That is partly driven by rising exports, as companies shift away from China not only due to political risks but also for economic reasons - Indian labour force is not only cheaper but also younger and still growing in size.

AIE has a near six-year track record of taking advantage of these opportunities, delivering strong outperformance in the process. Although there have been some arguments that the Indian stock market is overheated, we believe the AIE team has shown great aptitude in sorting the wheat from the chaff. They are valuation-conscious and aim to not buy at higher valuations unless the growth opportunity is there. The team also places a heavy emphasis on corporate governance, which has helped them avoid some poor performers in the last couple of years.

Of course, there are no guarantees that this rosy picture will continue indefinitely. Nonetheless, the wider macroeconomic picture remains positive for India and the country's stock market continues to deliver solid earnings growth. We think AIE remains an attractive vehicle to take advantage of these opportunities.

CLICK HERE TO READ THE FULL REPORT  Visit Kepler Trust Intelligence for more high quality independent investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABGGDXGBDDGSG
Date   Source Headline
26th Apr 20244:02 pmRNSNet Asset Value(s)
25th Apr 20243:14 pmRNSIssue of Equity
25th Apr 20241:11 pmRNSNet Asset Value(s)
25th Apr 202411:31 amRNSBlock Listing Application
24th Apr 20241:42 pmRNSNet Asset Value(s)
24th Apr 202412:19 pmRNSPublication of a Prospectus
23rd Apr 20241:07 pmRNSNet Asset Value(s)
23rd Apr 20248:49 amRNSHolding(s) in Company
22nd Apr 20242:23 pmRNSNet Asset Value(s)
19th Apr 202412:30 pmRNSNet Asset Value(s)
19th Apr 20247:00 amRNSBlock listing Interim Review
18th Apr 202412:52 pmRNSNet Asset Value(s)
17th Apr 20242:18 pmRNSNet Asset Value(s)
16th Apr 20242:00 pmRNSNet Asset Value(s)
16th Apr 20247:00 amRNSPublication - Circular & Notice of General Meeting
15th Apr 20242:14 pmRNSNet Asset Value(s)
12th Apr 202412:55 pmRNSNet Asset Value(s)
11th Apr 202412:46 pmRNSNet Asset Value(s)
10th Apr 202412:44 pmRNSNet Asset Value(s)
9th Apr 20245:53 pmRNSIssue of Equity
9th Apr 20241:09 pmRNSNet Asset Value(s)
9th Apr 20247:00 amRNSIssue of Equity
8th Apr 20241:22 pmRNSNet Asset Value(s)
5th Apr 202412:52 pmRNSNet Asset Value(s)
4th Apr 20243:09 pmRNSNet Asset Value(s)
3rd Apr 20241:25 pmRNSNet Asset Value(s)
2nd Apr 20241:24 pmRNSNet Asset Value(s)
2nd Apr 20247:00 amRNSTotal Voting Rights
28th Mar 20245:41 pmRNSIssue of Equity
28th Mar 20241:09 pmRNSNet Asset Value(s)
27th Mar 20245:27 pmRNSIssue of Equity
27th Mar 202412:54 pmRNSDirector/PDMR Shareholding
27th Mar 202412:41 pmRNSNet Asset Value(s)
26th Mar 20245:40 pmRNSIssue of Equity
26th Mar 20241:05 pmRNSNet Asset Value(s)
25th Mar 202412:06 pmRNSNet Asset Value(s)
22nd Mar 20244:23 pmRNSIssue of Equity
22nd Mar 20241:47 pmRNSNet Asset Value(s)
21st Mar 20245:21 pmRNSIssue of Equity
21st Mar 20241:43 pmRNSNet Asset Value(s)
20th Mar 20245:29 pmRNSIssue of Equity
20th Mar 202412:22 pmRNSNet Asset Value(s)
20th Mar 202410:18 amRNSResults analysis from Kepler Trust Intelligence
19th Mar 20241:10 pmRNSNet Asset Value(s)
18th Mar 20242:50 pmRNSNet Asset Value(s)
15th Mar 20241:13 pmRNSNet Asset Value(s)
14th Mar 20241:52 pmRNSNet Asset Value(s)
13th Mar 20241:00 pmRNSNet Asset Value(s)
12th Mar 20244:44 pmRNSIssue of Equity
12th Mar 20241:53 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.